Toxic epidermal, ecrolysis treated by intravenous immunoglobulines [4];Nécrose épidermique toxique traitée par immunoglobulines intraveineuses

Revue de Medecine Interne

Volumn 22, Issue 5, 2001, Pages 491-492

  Corne, P ^a   Dereure, O ^b   Guilhou, J J ^b   Jonquet, O ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Intravenous immunoglobulins; Toxic epidermal necrolysis

Indexed keywords

BACAMPICILLIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORBUTOL; FAS ANTIGEN; FLAMMACERIUM; IMMUNOGLOBULIN; PARACETAMOL; PREDNISONE;

ADULT; CASE REPORT; FEMALE; FEVER; HUMAN; LETTER; PHARYNGITIS; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS;

EID: 0343408260     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00378-2     Document Type: Letter

References (14)

1. Roujeau J.C., Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J M. 331:1994;1272-1285.
2. Roujeau J.C. Syndrome de Lyell (nécrolyse épidermique toxique). Godeau P, Herson S, Piette J.C. Traité de médecine. 1996;716-717 Flammarion Médecine-Science, Paris.
3. Lipper G.M., Arndt K.A., Dover J.S. Recent therapeutic advances in dermatology. JAMA. 283:2000;175-177.
4. Redondo P., de Felipe I., de la Pena A., Aramendia J.M., Vanaclocha V. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. Br J Dermatol. 136:1997;645-646.
5. Jarret P., Rademaker M., Havill J., Pullon H. Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor. Clin Exp Dermatol. 22:1997;146-147.
6. Egan C.A., Grant W.J., Morris S.E., Saffle J.R., Zone J.J. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol. 40:1999;458-461.
7. Furubacke A., Berlin G., Anderson C., Sjoberg F. Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis ? Intensive Care M. 25:1999;1307-1310.
8. Sanclemente G., de la Roche C.A., Escobar C.E., Falabella R. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome. Int J Dermatol. 38:1999;878-879.
9. Wolkenstein P., Latarjet J., Roujeau J.C., Duguet C., Boudeau S., Vaillant L., et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 352:1998;1586-1589.
10. Heng M.C., Allen S.G. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol. 25:1991;778-786.
11. Halebian P.H., Corder V.J., Madden M.R., Finklestein J.L., Shires G.T. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 204:1986;503-512.
12. Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:1998;490-493.
13. Phan T., Wong R.C., Crotty K., Adelstein S. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin. Aust J Dermatol. 40:1999;153-157.
14. Magina S., Lisboa C., Gonçalves E., Conceiçao F., Leal V., Mesquita-Guimaraes J. A case of toxic epidermal necrolysis treated with intravenous immunoglobulin. Br J Dermatol. 142:1999;191-192.